SOHM, Inc. (SHMN)
OTCMKTS
· Delayed Price · Currency is USD
0.0008
+0.0001 (14.29%)
May 13, 2025, 12:39 PM EDT
SOHM, Inc. Revenue
In the year 2012, SOHM, Inc. had annual revenue of $1.30M, down -3.27%. SOHM, Inc. had revenue of $291.24K in the quarter ending December 31, 2012, with 35.18% growth.
Revenue
1.30M
Revenue Growth
+115.16%
P/S Ratio
1.24
Revenue / Employee
8.94K
Employees
145
Market Cap
1.61M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
SOHM, Inc. News
- 7 days ago - SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery - Accesswire
- 11 days ago - Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization - Accesswire
- 12 days ago - SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology - Accesswire
- 15 days ago - SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies - Accesswire
- 27 days ago - SOHM, Inc. Announces Patent Allowance/Approval in South Korea - Accesswire
- 4 weeks ago - SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE - Accesswire
- 5 weeks ago - SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations - Accesswire
- 2 months ago - SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology - Accesswire